AstraZeneca reported $26.29B in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Alcon AG ALC:SW USD 2.78B 448M
Amgen AMGN:US USD 15.69B 1.36B
Artemis Alpha ATS:LN GBP 5.37M 25K
AstraZeneca AZN:LN USD 26.29B 1.44B
AstraZeneca AZN:SS USD 26.29B 1.44B
Astrazeneca AZN:US USD 26.29B 1.44B
Bayer BAYN:GR EUR 35.08B 1.91B
Biogen BIIB:US USD 3.27B 653.6M
Galapagos GLPG:NA EUR 522.54M 9.67M
Genmab GEN:DC DKK 1.82B 1.16B
Gilead Sciences GILD:US USD 11.24B 814M
GlaxoSmithKline GSK:LN GBP 22.81B 1.86B
Hikma Pharmaceutical HIK:LN USD 1.08B 67M
Lonza Group LONN:SW CHF 3.08B 454M
Merck MRK:GR EUR 9.51B 101M
Novartis NOVN:VX USD 28.66B 496M
Orion ORNBV:FH EUR 275.4M 23.3M
Recordati REC:IM EUR 778.04M 73.16M
Regeneron Pharmaceuticals REGN:US USD 3.85B 969.9M
Roche Holding ROG:VX 27.24B 170M